Atlas Trials

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Clinical trial NCT01924624 · UNKNOWN

Trial details

NCT number
NCT01924624
Sponsor
The First Affiliated Hospital of Xiamen University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular CarcinomaRecurrence
Start date
2013-07-01
Primary completion
2015-08-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.